Closing the Loop

Closing the Loop
Closing the Loop
 

Surface:  All things to all sales reps?

With Microsoft's Surface tablet now perceived as a viable alternative to the iPad, some medical marketers wonder if Surface may become the only device sales reps need in the field.

Currently, most reps need to jostle at least two units in the field to ensure they're ready for anything. With the iPad, they can unveil beautiful presentations enhanced by Big Data analytics.

But they still need their laptop to showcase more presentation material and data nested in Excel, Powerpoint and other Microsoft software programs.

With a Surface, they're can do both—and leave the iPad behind.  “From a home office perspective, much of what is shared with the sales force is still based in Excel and PowerPoint,” says Merz's Morgan, who is interested in moving to the Surface as an all-in-one unit.  “Ideally, we want the sales force to carry one device that meets 100% of their work needs.”

Makes sense. But for the time being, it looks like the iPad's firm grasp on the medical marketing industry will take a while to weaken—if ever, according to StayinFront's Arbadji.  “We can see the case for Surface,” he says. “But we are not seeing this in practice as yet. StayinFront supports both platforms, but for our clients so far, iPad continues to dominate the mobile rep space.”

Page 2 of 2
You must be a registered member of MMM to post a comment.
close

Next Article in Directories

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.